Literature DB >> 24811831

Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma.

Wilko Weichert1, Arne Warth.   

Abstract

PURPOSE OF REVIEW: This review gives a comprehensive overview on recent developments in the classification of neoplastic lung lesions with lepidic growth patterns, comprising the adenocarcinoma (ADC) precursor lesions atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ (AIS), and minimally invasive adenocarcinoma (MIA) as well as lepidic predominant adenocarcinoma (LPA). RECENT
FINDINGS: The concept of a continuum between the precursor lesions AAH and AIS to MIA and frankly invasive ADC is backed by a wealth of recent data showing a gradual decrease in overall survival from 100% for AAH, AIS, and MIA to moderately lower rates for LPA. Further, it has been shown that the morphologic categorization of these tumors can be done with reasonable reliability and that nonmucinous lepidic tumors show distinct molecular alterations with high rates of epidermal growth factor receptor mutations. Importantly, lepidic tumor growth is also mirrored by specific characteristics in computed tomography images, arguing for a combined assessment of histomorphology and imaging data for an optimized classification of lepidic neoplasms.
SUMMARY: The validity and clinical importance of the novel concept of ADC precursor lesions and LPA have been confirmed by clinical, radiological, morphological, and molecular data. Thereby, it has evolved into a valuable tool to aid in clinical decision-making.

Entities:  

Mesh:

Year:  2014        PMID: 24811831     DOI: 10.1097/MCP.0000000000000065

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  25 in total

Review 1.  [Lung cancer. Developments, concepts and preview of the new WHO classification].

Authors:  I Petersen; A Warth
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

Review 2.  [The new TNM classification for lung tumors : Changes and the assessment of multiple tumor foci].

Authors:  A Harms; M Kriegsmann; L Fink; F Länger; A Warth
Journal:  Pathologe       Date:  2017-02       Impact factor: 1.011

3.  Comprehensive study of mutational and clinicopathologic characteristics of adenocarcinoma with lepidic pattern in surgical resected lung adenocarcinoma.

Authors:  Ye Xu; Chen Zhu; Wenliang Qian; Min Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2016-10-13       Impact factor: 4.553

Review 4.  [Molecular diagnostics of non-small cell lung cancer: New markers and technologies].

Authors:  A Warth; V Endris; M Kriegsmann; A Stenzinger; R Penzel; N Pfarr; W Weichert
Journal:  Pathologe       Date:  2015-03       Impact factor: 1.011

Review 5.  [Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].

Authors:  A Warth
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

6.  Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma.

Authors:  Claudio R Scafoglio; Brendon Villegas; Gihad Abdelhady; Sean T Bailey; Jie Liu; Aditya S Shirali; W Dean Wallace; Clara E Magyar; Tristan R Grogan; David Elashoff; Tonya Walser; Jane Yanagawa; Denise R Aberle; Jorge R Barrio; Steven M Dubinett; David B Shackelford
Journal:  Sci Transl Med       Date:  2018-11-14       Impact factor: 17.956

Review 7.  Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology.

Authors:  Jian-Wei Gao; Stefania Rizzo; Li-Hong Ma; Xiang-Yu Qiu; Arne Warth; Nobuhiko Seki; Mizue Hasegawa; Jia-Wei Zou; Qian Li; Marco Femia; Tang-Feng Lv; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2017-02

8.  Semiquantitative Computed Tomography Characteristics for Lung Adenocarcinoma and Their Association With Lung Cancer Survival.

Authors:  Hua Wang; Matthew B Schabath; Ying Liu; Anders E Berglund; Gregory C Bloom; Jongphil Kim; Olya Stringfield; Edward A Eikman; Donald L Klippenstein; John J Heine; Steven A Eschrich; Zhaoxiang Ye; Robert J Gillies
Journal:  Clin Lung Cancer       Date:  2015-05-27       Impact factor: 4.785

Review 9.  Lung cancer: developments, concepts, and specific aspects of the new WHO classification.

Authors:  Iver Petersen; Arne Warth
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-22       Impact factor: 4.553

Review 10.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.